Hamid Khoja insider trades: FibroBiologics (FBLG) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hamid reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | FBLG | ↑ Buy | 30,000 | $0.38 | $11K | Direct | Mar 5, 2026 (1d) |
| May 27, 2025 | FBLG | ↑ Buy | 20,000 | $0.84 | $17K | Direct | May 27, 2025 (0d) |
| Aug 12, 2024 | FBLG | ↑ Buy | 10,000 | $1.90 | $19K | Direct | Aug 12, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FBLG insiders
Open-market trades in the last 12 months
About Hamid Khoja's insider trades
Hamid Khoja is Chief Scientific Officer at FibroBiologics (FBLG). Since Aug 12, 2024, Hamid has reported 3 open-market purchases worth $47K and no sales on SEC Form 4. In the last 12 months: 1 buy ($11K).
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FBLG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.